The case stems from a Cronobacter bacterial contamination at one of Abbott Laboratories' Michigan plants.

Under the settlement, Abbott will pay a total of $384,999,040 to resolve allegations under the False Claims Act.

Baby formula maker Abbott Laboratories agreed to pay nearly $385 million to resolve a civil False Claims Act case with the Justice Department and some states stemming from a Cronobacter bacterial ...

Abbott Laboratories’ cancer diagnostic wing, formerly Madison-based Exact Sciences, is launching a blood test to screen for ...

Abbott Laboratories (NYSE: ABT) and Pfizer (NYSE: PFE) both delivered Q1 2026 beats, yet the market treats them differently. Abbott is down 22.99% year to date after a medtech correction. Pfizer sits ...

Long-term growth matters more than a single quarter. Abbott benefits from multiple healthcare growth trends. Management's outlook could move shares more than earnings. Abbott Laboratories (NYSE: ABT) ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Abbott is a healthcare leader providing diagnostics, nutrition, and cardiovascular tools to a global audience. Its March 2026 acquisition of Exact Sciences added advanced cancer diagnostics to its ...

Abbott leads in absolute revenue, but Intuitive Surgical's growth rate tells a different story over the past eight quarters.

Abbott (ABT) is down 23% year to date with insiders buying near $92; Pfizer (PFE) pairs a 7% yield with a collapsing COVID revenue base. Pfizer's patent cliffs cost $1.5B this year, buybacks are ...